News
-
-
-
PRESS RELEASE
Onco-Innovations CEO Thomas O’Shaughnessy Featured on Conversations That Matter to Discuss Breakthroughs in Cancer Treatment, AI Integration, and Potential Global Expansion
Onco-Innovations Limited's CEO, Thomas O'Shaughnessy, featured in an exclusive interview on Conversations That Matter discussing the Company's efforts in developing cancer treatment and strategic partnerships -
-
-
-
-
-
PRESS RELEASE
Onco-Innovations' PKNP Technology Shown in Study to Demonstrate Low Toxicity and High Safety Profile
Onco-Innovations Limited announces successful preclinical study results of its second-generation nanoparticle formulation of PNKP Compound, showing enhanced inhibitor delivery with minimal toxicity for potential cancer therapy -